CAS 1515855-97-6

Fórmula: C23H22N4O5

InChI: InChI=1S/C23H22N4O5/c28-23(27-12-24-11-25-27)26-7-5-15(6-8-26)22(16-1-3-18-20(9-16)31-13-29-18)17-2-4-19-21(10-17)32-14-30-19/h1-4,9-12,15,22H,5-8,13-14H2

Clave InChI: CLSNATLUIXZPMV-UHFFFAOYSA-N

SMILES: C1CN(CCC1C(C2=CC3=C(C=C2)OCO3)C4=CC5=C(C=C4)OCO5)C(=O)N6C=NC=N6

(4-(Bis(Benzo[D][1,3]Dioxol-5-Yl)Methyl)Piperidin-1-Yl)(1H-1,2,4-Triazol-1-Yl)Methanone

CAS: 1515855-97-6

(4-(Bis(Benzo[D][1,3]Dioxol-5-Yl)Methyl)Piperidin-1-Yl)(1H-1,2,4-Triazol-1-Yl)Methanone

Fórmula: C₂₃H₂₂N₄O₅

Pureza: 98%

Peso molecular: 434.44

Ref: 54-OR1008151

JJKK 048

CAS: 1515855-97-6

JJKK 048

Fórmula: C₂₃H₂₂N₄O₅

Pureza: 99.5%

Peso molecular: 434.44

Ref: 54-BUP12993

(4-(Bis(Benzo[D][1,3]Dioxol-5-Yl)Methyl)Piperidin-1-Yl)(1H-1,2,4-Triazol-1-Yl)Methanone

CAS: 1515855-97-6

Fórmula: C₂₃H₂₂N₄O₅

Pureza: 98%

Forma y color: Solid

Peso molecular: 434.4446

Ref: IN-DA01E2A6

JJKK 048

CAS: 1515855-97-6

JJKK 048 is a fatty acid drug that has been shown to be effective in treating inflammatory bowel disease. JJKK 048 is an amide of 2-arachidonoylglycerol, a cannabinoid that activates cannabinoid receptors and stimulates the release of monoacylglycerol and 2-arachidonoylglycerol. It also exhibits pharmacokinetic properties that are similar to those of other cannabinoid drugs, such as a low volume of distribution and high plasma protein binding. JJKK 048 has been shown to decrease symptoms in patients with chronic kidney disease, including hypomotility, piperazine, and polyuria. This drug is also being studied for its potential use in cancer treatment.

Fórmula: C₂₃H₂₂N₄O₅

Pureza: Min. 95%

Peso molecular: 434.44 g/mol

Ref: 3D-QKC85597

JJKK 048

CAS: 1515855-97-6

JJKK 048 is a potent and selective MAGL inhibitor.

Fórmula: C₂₃H₂₂N₄O₅

Pureza: 99.77%

Forma y color: Solid

Peso molecular: 434.44

Ref: TM-T15614